Sub-therapeutic Dosing In Pediatric Trials To Be Reviewed By FDA's Pediatric Ethics Subcommittee
This article was originally published in The Pink Sheet Daily
Executive Summary
Panel is called in to shed light in a growing but still controversial area.
You may also be interested in...
Children's Participation In Clinical Trials To Be Subject Of FDA Guidance
But the actual publication of a draft guidance is probably some years off, an FDA official said at a meeting of the agency's Pediatric Ethics Subcommittee.
Children's Participation In Clinical Trials To Be Subject Of FDA Guidance
But the actual publication of a draft guidance is probably some years off, an FDA official said at a meeting of the agency's Pediatric Ethics Subcommittee.
Advisory Committee To Revisit Boxed Warning For Protopic, Elidel
Six years after recommending boxed warnings and medication guides for Novartis' Elidel (pimecrolimus) and Astellas' Protopic (tacrolimus), the Pediatric Advisory Committee will hear updates on their safety.